ArticleThe Korean journal of internal medicine2015
Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies.
Article in The Korean journal of internal medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 39 citations in OpenAlex.
- Article
- Acute respiratory distress syndrome in patients with cancer: the YELENNA prospective multinational observational cohort study.Intensive care medicine · 2025Observational
- Outcomes of extracorporeal membrane oxygenation support in pediatric hemato-oncology patients.Acute and critical care · 2024Article
- Extracorporeal membrane oxygenation in critically ill patients with active hematologic and non-hematologic malignancy: a literature review.Frontiers in medicine · 2024Review
- Extracorporeal membrane oxygenation in immunocompromised patients with acute respiratory failure: A retrospective cohort study.The clinical respiratory journal · 2023Article
- Advances in the use of ECMO in oncology patient.Cancer medicine · 2023Review
- Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis.Intensive care medicine · 2022Article
- Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.Intensive care medicine · 2021Article
- ECMO Support in Pre-B-Cell ALL for Disseminated Legionnaire's Disease.The journal of extra-corporeal technology · 2021Article
- Extracorporeal membrane oxygenation in a patient with newly diagnosed acute myeloblastic leukaemia presenting with severe respiratory failure.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2021Article
- Review
- Extra-corporeal membrane oxygenation for severe respiratory failure in the UK.Journal of the Intensive Care Society · 2020Article
- The Utility of Extracorporeal Membrane Oxygenation in Patients With Hematologic Malignancies: A Literature Review.Cureus · 2020Review
- Article
- Extracorporeal Life Support in Adult Patients with Hematologic Malignancies and Acute Circulatory and/or Respiratory Failure.The Korean journal of thoracic and cardiovascular surgery · 2019Article
- Extracorporeal membrane oxygenation support in patients with hematologic malignancies: to whom and when?The Korean journal of internal medicine · 2017Article
- The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.Intensive care medicine · 2017Review
- Extracorporeal membrane oxygenation as a rescue therapy for acute respiratory failure during chemotherapy in a patient with acute myeloid leukemia.Journal of thoracic disease · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimsThe clinical outcomes of patients with hematologic malignancies who were treated with extracorporeal membrane oxygenation (ECMO) after the failu re of optimal conventional therapy were determined.
methodsThe medical records of all patients administered ECMO during their stay in a medical intensive care unit of Seoul St. Mary's Hospital between February 2010 and July 2013 were reviewed retrospectively.
resultsIn total, 15 patients with hematologic malignancies were compared to 33 immunocompetent patients with documented cardiorespiratory failure. Underlying hematologic malignancies were significantly associated with lower overall survival (0.0% vs. 24.2%, p = 0.044). Mortality was significantly associated with a higher 24 hours ECMO inspired fraction of oxygen (0.71 ± 0.24 vs. 0.47 ± 0.13, p = 0.015), the development of infection after ECMO (87.5% vs. 25.0%, p = 0.001), and the presence of hyperbilirubinemia (70.0% vs. 0.0%, p < 0.001). Matching of the patients based on their Acute Physiology and Chronic Health Evaluation II scores confirmed the greater risk of mortality in patients with hematologic malignancies (survival: 0.0% vs. 40.0%, p = 0.017). The mean difference in inotropic-equivalent scores after ECMO was significantly lower in the immunocompetent patients than in those with hematologic malignancies (-59.22 ± 97.83 vs. 53.87 ± 164.46, p = 0.026).
conclusionsPatients with hematologic malignancies who require ECMO for respiratory support have poor outcomes. The incidence of complications in these patients did not significantly differ from that in immunocompetent patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.